Last reviewed · How we verify
A Randomized, Double-blind, Placebo-controlled, Parallel, Multi-center, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients
This study aims to evaluate the efficacy and safety of IN-115314 Ointment in mild to moderate atopic dermatitis adult patients
Details
| Lead sponsor | HK inno.N Corporation |
|---|---|
| Phase | Phase 2 |
| Status | NOT_YET_RECRUITING |
| Enrolment | 162 |
| Start date | 2025-07 |
| Completion | 2026-09-30 |
Conditions
- Mild to Moderate Atopic Dermatitis
Interventions
- IN-115314 Ointment 1%
- IN-115314 Ointment 3%
- IN-115314 Ointment placebo
Primary outcomes
- Change rate in EASI score from the baseline after treatment — 4 weeks